Hood River Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.8M	Buy	371,503 +5,327	+1%	+$920K	0.63%	53
2025 Q4	$66.9M	Buy	366,176 +6,219	+2%	+$868K	0.73%	53
2025 Q3	$43.7M	Sell	359,957 -11,147	-3%	-$1.26M	0.52%	67
2025 Q2	$38.7M	Buy	+371,104	New	+$39.3M	0.54%	65
2025 Q1	–	Sell	-644,785	Closed	-$54.6M	–	147
2024 Q4	$54.6M	Buy	644,785 +19,701	+3%	+$1.81M	0.81%	45
2024 Q3	$56.2M	Buy	625,084 +76,018	+14%	+$6.64M	0.91%	42
2024 Q2	$44.2M	Buy	549,066 +28,316	+5%	+$2.1M	0.92%	38
2024 Q1	$41.6M	Buy	520,750 +127,997	+33%	+$10.7M	0.93%	39
2023 Q4	$31.3M	Buy	392,753 +9,477	+2%	+$634K	0.86%	46
2023 Q3	$26.8M	Sell	383,276 -1,085	-0.3%	-$81.1K	0.86%	51
2023 Q2	$27.6M	Buy	384,361 +3,539	+0.9%	+$261K	0.82%	55
2023 Q1	$23.5M	Sell	380,822 -79,473	-17%	-$5.22M	0.76%	51
2022 Q4	$35.5M	Buy	+460,295	New	+$27.5M	1.29%	29